Zn-and Mg-Containing Tricalcium Phosphates-Based Adjuvants for Cancer Immunotherapy

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Wang, Xiupeng ^a   Li, Xia ^a   Onuma, Kazuo ^a   Sogo, Yu ^a   Ohno, Tadao ^b   Ito, Atsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CANCER VACCINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; MAGNESIUM; VACCINE; ZINC;

ANIMAL; ARTICLE; BACILLUS; BIOSYNTHESIS; CHEMISTRY; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MACROPHAGE; METABOLISM; MORTALITY; MOUSE; NEOPLASM; SPLEEN; NEOPLASMS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACILLUS; CALCIUM PHOSPHATES; CANCER VACCINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY; MACROPHAGES; MAGNESIUM; MICE; NEOPLASMS; SPLEEN; VACCINES, CONJUGATE; ZINC;

EID: 84880386987     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02203     Document Type: Article

References (41)

1. Blattman, J. N. & Greenberg, P. D. Cancer immunotherapy: a treatment for the masses. Science 305, 200-205 (2004). (Pubitemid 38886725)
2. Pashine, A., Valiante, N. M. & Ulmer, J. B. Targeting the innate immune response with improved vaccine adjuvant. Nat Med 11, s63-s68 (2005). (Pubitemid 40562305)
3. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
4. Kobatake, H. et al. Studies on hot water extract of Mycobacterium- tuberculosis .1. Structural-analyses of polysaccharides. Yakugaku Zasshi 101, 713-722 (1981). (Pubitemid 12204168)
5. Oka, H. et al. Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1 T cell responses. Biol Pharm Bull 27, 82-88 (2004). (Pubitemid 41656678)
6. Sasaki, H., Schmitt, D., Hayashi, Y., Pollard, R. B. & Suzuki, F. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from mycobacterium-tuberculosis-the importance of lymphocytes infiltrated into tumor sites. Nat Immun 12, 104-112 (1993). (Pubitemid 23161054)
7. Kobayashi, M., Pollard, R. B. & Suzuki, F. Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma. Anti-Cancer Drug 8, 156-163 (1997). (Pubitemid 27102230)
8. Oka, H. et al. An immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis, Z-100, restores the balance of Th1/Th2 cell responses in tumor bearing mice. Immunol Lett 70, 109-117 (1999). (Pubitemid 29467450)
9. Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-U1113 (2008).
10. Ali, O. A.,Huebsch, N., Cao, L., Dranoff, G. & Mooney, D. J. Infection-mimicking materials to program dendritic cells in situ. Nature Materials 8, 151-158 (2009).
11. Wang, X., Li, X., Sogo, Y. & Ito, A. Simple synthesis route of mesoporous AlOOH nanofibers to enhance immune responses. RSC Advances 3, 8164-8167 (2013).
12. Li, X. et al. Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy. Adv Healthc Mater, http://dx.doi.org/10.1002/adhm.201200149 (2013).
13. Wang, X., Li, X., Ito, A., Sogo, Y. & Ohno, T. Particle-size- dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater 9, 7480-7849 (2013).
14. Gupta, R. K. et al. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11, 293-306 (1993).
15. Prasad, A. S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr 12, 646-652 (2009).
16. Bao, B., Prasad, A. S., Beck, F. W. J. & Godmere, M. Zinc modulates mRNA levels of cytokines. Am J Physiol-Endoc M 285, E1095-E1102 (2003). (Pubitemid 37296332)
17. Mcmillan, R. M., Macintyre, D. E., Beesley, J. E. & Gordon, J. L. Regulation of macrophage lysosomal enzyme-secretion: role of arachidonate metabolites, divalent-cations and cyclic-amp. J Cell Sci 44, 299-315 (1980). (Pubitemid 10020007)
18. Li, X., Ito, A., Sogo, Y.,Wang, X. P. & LeGeros, R. Z. Solubility of Mg-containing beta-tricalcium phosphate at 25 degrees C. Acta Biomater 5, 508-517 (2009).
19. Ito, A. et al. Resorbability and solubility of zinc-containing tricalcium phosphate. J Biomed Mater Res 60, 224-231 (2002). (Pubitemid 34194583)
20. Ito, A.,Ojima, K.,Naito, H., Ichinose, N., Tateishi, T. Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res 50, 178-183 (2000). (Pubitemid 30126962)
21. Wang, X. P. et al. Mesoporous bioactive glass coatings on stainless steel for enhanced cell activity, cytoskeletal organization and AsMg immobilization. J Mater Chem 20, 6437-6445 (2010).
22. Wang, X. P. et al. Ascorbate-apatite composite and ascorbate-FGF-2- apatite composite layers formed on external fixation rods and their effects on cell activity in vitro. Acta Biomater 5, 2647-2656 (2009).
23. Wang, X. P., Ito, A., Sogo, Y., Li, X. & Oyane, A. Zinc-containing apatite layers on external fixation rods promoting cell activity. Acta Biomater 6, 962-968 (2010).
24. Wang, X., Ito, A., Li, X., Sogo, Y.& Oyane, A. Signal molecules-calcium phosphate coprecipitation and its biomedical application as a functional coating. Biofabrication 3, 022001 (2011).
25. Wang, X. P., Ito, A., Sogo, Y., Li, X. & Oyane, A. Silicate-apatite composite layers on external fixation rods and in vitro evaluation using fibroblast and osteoblast. J Biomed Mater Res A 92A, 1181-1189 (2010).
26. Kanzaki, N., Onuma, K., Treboux, G., Tsutsumi, S. & Ito, A. Inhibitory effect of magnesium and zinc on crystallization kineyics of hydroxyapatite (0001) face. J Phys Chem B 104, 4189-4194 (2000).
27. John, E. et al. Zinc in innate and adaptive tumor immunity. J Transl Med 8, 118-134 (2010).
28. Kitamura, H. et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 7, 971-977 (2006). (Pubitemid 44263911)
29. Sugiura, T., Kuroda, E. & Yamashita, U. Dysfunction of macrophages in metallothionein-knock out mice. J UOEH 26, 193-205 (2004). (Pubitemid 38855688)
30. Lange, T. et al. Proinflammatory and osteoclastogenic effects of betatricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. Biomaterials 30, 5312-5318 (2009).
31. Sabel, M. S. Cryo-immunology: A review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 58, 1-11 (2009).
32. Berinstein, N. L. Enhancing cancer vaccines with immunomodulators. Vaccine 25, B72-B88 (2007).
33. Beadling, C., Johnson, K. W. & Smith, K. A. Isolation of Interleukin-2-Induced Immediate-Early Genes. P Natl Acad Sci USA 90, 2719-2723 (1993).
34. Smith, K. A. Interleukin-2-Inception, Impact, and Implications. Science 240, 1169-1176 (1988).
35. Old, L. J. Tumor necrosis factor (TNF). Science 230, 630-632 (1985). (Pubitemid 16190956)
36. Helson, L., Green, S., Carswell, E. & Old, L. J. Effect of tumor necrosis factor on cultured human melanoma cells. Nature 258, 731-732 (1975).
37. Watford, W. T.,Moriguchi, M.,Morinobu, A. & O'Shea, J. J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth F R 14, 361-368 (2003). (Pubitemid 37099449)
38. Schoenborn, J. R. , Wilson, C. B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96, 41-101 (2007). (Pubitemid 350018717)
39. Noda, K. et al. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low-or high-dose Z-100: Treatment with immunomodulator, more is not better. Gynecol Oncol 101, 455-463 (2006). (Pubitemid 43729978)
40. Wellinghausen, N., Kirchner, H. & Rink, L. The immunobiology of zinc. Immunol Today 18, 519-521 (1997). (Pubitemid 27488099)
41. Wang, X., Li, X., Ito, A., Sogo, Y. & Ohno, T. Pore-size dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy. J Biomed Mater Res A, http://dx.doi.org/10.1002/jbm.a.34783 (2013).